Tuesday 17 November 2026 Sign in / SubscribeFree daily emailMarket analysisEnterpriseVigiEye regulatory newsCompePharma CRM & HR →
The business of pharma
Financing

Grande Group signs $40M ordinary share purchase facility with White Lion Capital

Grande Group Limited, a British Virgin Islands company, entered into an ordinary share purchase agreement with White Lion Capital, LLC on July 16, 2026. Under it, the company may sell up to $40 million of newly issued ordinary shares over 36 months, with each purchase capped at $3 million unless the investor raises the limit. The investor also receives commitment shares, and a registration rights agreement covers resale of the shares. The excerpt does not identify any product or indication.

16 Nov 2026 · Grande Group Ltd/HK GRAN · Company news

Company's press release (SEC filing): Grande Group Ltd/HK ↗

Written by CompePharma's editorial system from the company's filing; claims are the company's. AI-assisted; check the source before acting. Not investment advice.

More FinancingAll →